GLP-1s and Cardiovascular Risk in Patients with Type 2 Diabetes: Translating Outcomes Data into Clinical Practice
September 15, 2026
5:30 pm
Expired
Heart Failure Redefined: Advancing Care in HFpEF and HFmrEF
September 16, 2026
5:30 pm
Upcoming
Mind the Gap: Strengthening Access Pathways in Obesity Care
September 17, 2026
5:30 pm
Upcoming
Mind the Gap: Strengthening Access Pathways in Obesity Care
September 24, 2026
5:30 pm
Upcoming
Elevating the Pharmacist’s Role in Optimizing Adjuvant Care for High-Risk cSCC
September 29, 2026
5:30 pm
Upcoming
GLP-1s and Cardiovascular Risk in Patients with Type 2 Diabetes: Translating Outcomes Data into Clinical Practice
September 29, 2026
5:30 pm
Upcoming
Elevating the Pharmacist’s Role in Optimizing Adjuvant Care for High-Risk cSCC
September 30, 2026
5:30 pm
Upcoming
Mind the Gap: Strengthening Access Pathways in Obesity Care
October 1, 2026
5:30 pm
Upcoming
Elevating the Pharmacist’s Role in Optimizing Adjuvant Care for High-Risk cSCC
October 1, 2026
5:30 pm
Upcoming
Optimizing Frontline Therapy for CML: Balancing Efficacy, Safety, and Long-Term Tolerability
October 8, 2026
5:30 pm
Upcoming
GLP-1s and Cardiovascular Risk in Patients with Type 2 Diabetes: Translating Outcomes Data into Clinical Practice
October 8, 2026
5:30 pm
Upcoming
PD-L1 Inhibitors in NSCLC: Precision, Personalization, and Practice Impact
October 14, 2026
5:30 pm
Upcoming